Pharma (ANIP) 2025 Earnings: ANIP Financial Outlook
ANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...
Learn when to do a Backdoor Roth in 2026, including optimal timing around income, limits, and market conditions.
15,255 articlesANI Pharma's Q4 2025 results set the stage for the pharma space. This guide breaks down what the numbers mean for the...
Kroger reports fiscal 2025 results with a GAAP payout surge caused by a major impairment, yet cash flow and 2026 earn...
What Mineralys (MLYS) reported in its 2025 earnings reveals more than numbers. This guide breaks down the quarter, th...
A veteran trader explains why dividend-heavy healthcare equities remain a bedrock in 2026 markets, drawing on two dec...
A no-action relief granted to Phantom allows crypto wallets to function as consumer interfaces for regulated derivati...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
A new Grok AI forecast linked to Elon Musk projects XRP reaching up to $7 by late 2026. The forecast comes as ETFs, r...
New data show a modest easing in AD&C lending pressure in Q1 2026, though lenders remain cautious. NAHB and Fed surve...
IBM and Oracle have quietly strengthened AI backlogs and earnings, setting up a potential late-2026 surprise as marke...
Amazon is edging toward a $3 trillion market cap as cloud growth and aggressive capital spending power a potential mi...
A May 2026 poll defines a new voter cohort—the disillusioned—showing widespread financial strain and a belief that th...
A $10,000 investment in Asia’s biggest stocks grew to $15,267 by June 3, 2026, outpacing most U.S. large caps and hig...